Study | Intervention name | Results | Unit of analysis | Time point | Type of assay | Population | |
GMT (95% CI) | GMR (95% CI) | ||||||
Heterologous booster versus homologous booster | |||||||
Li 2021a |
CoronaVac/Ad5 booster | 3090.10 (2636.10 to 3622.30) | 8.37 (6.52 to 10.75) | Not reported | 14 days after boost | ELISA | 18–59 years |
CoronaVac/CoronaVac boost | 369 (304.20 to 447.50) |